The story
In June 1948 the Boston pathologist Sidney Farber published a paper in the New England Journal of Medicine reporting that a chemical called aminopterin had caused temporary remissions in children with acute leukemia. Of 16 children treated at Children's Hospital Boston, 10 improved, and some regained appetite, energy and normal blood counts for a time. The remissions were short, and the children relapsed, but they were the first demonstration that a drug could push back leukemia, and the paper marked the start of modern cancer chemotherapy.
At the time, acute leukemia in children was a death sentence within months, and doctors had little more to offer than transfusions. Farber had noticed that folic acid, a vitamin newly synthesized in the 1940s, appeared to speed up the growth of leukemia cells in children given it, since cancer cells divide fast and need it to make DNA. He asked whether a molecule that blocked folic acid might slow them. He obtained aminopterin from the chemist Yellapragada Subbarow's team at Lederle Laboratories. Earlier, in the 1940s, nitrogen mustard, a derivative of the chemical weapon, had shown activity against lymphoma at Yale, but Farber's results were the first for childhood leukemia.
Colleagues were skeptical, and some thought it cruel to give toxic drugs to dying children. Farber persisted and, with the businesswoman and activist Mary Lasker, built a powerful campaign for cancer research funding that culminated in the National Cancer Act of 1971. Aminopterin was replaced by methotrexate, and in the 1950s and 1960s researchers at the National Cancer Institute, including Emil Freireich and Emil Frei, showed that combinations of drugs given together could produce lasting remissions. Today about 90 percent of children with the most common form of leukemia in wealthy countries survive.
Why it mattered
- Targeted drugs followed, including tamoxifen for breast cancer and Gleevec for a form of leukemia, which block specific molecules that cancer cells depend on.
- Combination chemotherapy turned childhood leukemia from a fatal disease into one that is usually cured.
- The drug-testing system for cancer expanded, with large clinical trials run by national research networks.
- Public funding and fundraising for cancer research grew, as with the Jimmy Fund that Farber helped found.
Sources
- Sidney Farber, MD Dana-Farber Cancer Institute
- Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948 James Lind Library
- Einar Gustafson, Jimmy, was inspiration for the Jimmy Fund Jimmy Fund
- Survival Rates for Childhood Leukemia American Cancer Society
- Pediatric Pathologist Sidney Farber, MD: The Father of Modern Chemotherapy and Cofounder of the Jimmy Fund The ASCO Post
Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made
Community notes
Loading notes…